Cassava Sciences Inc vs Kinder Morgan Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Kinder Morgan Inc trades at $31.6 (market cap $70.10B). The key difference: Kinder Morgan Inc is far larger — about 1468.1× Cassava Sciences Inc's market cap, and Kinder Morgan Inc pays a 3.75% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | KMI | |
|---|---|---|
Market Cap | $47.75M | $70.10B |
Sector | Health | Energy |
52-Week High | $4.64 | $34.31 |
52-Week Low | $0.87 | $25.84 |
Enterprise Value | -$34.93M | $102.15B |
Dividend Yield | — | 3.75% |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →